ILLUMENATE Pivotal Post-Approval Study (PAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT03421561

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03421561
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03421561. Randomized; double masking; primary purpose treatment. Start 2013-06-18 (actual); primary completion 2017-12-08 (actual). Results posted on 2024-02-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ILLUMENATE Pivotal Post-Approval Study (PAS)
Condition
Peripheral Artery Disease
Intervention (Device)
Stellarex 0.035" OTW Drug-coated Angioplasty Balloon
Intervention (Device)
EverCross™ 0.035 PTA Balloon Catheter
Lead sponsor
Spectranetics Corporation (class: industry)

Record details

Record id
cardio:ct-nct03421561
Content hash
7df519459d20474f711bb59910a63be9f268df69b02cce2f664a47aafe41963a